OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Purinergic Signalling: Therapeutic Developments
Geoffrey Burnstock
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 347

Showing 51-75 of 347 citing articles:

Unlocking the therapeutic potential of P2X7 receptor: a comprehensive review of its role in neurodegenerative disorders
Xiaoming Liu, Yiwen Li, Liting Huang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5

The P2X7 receptor: a new therapeutic target in Alzheimer’s disease
Péter Illés, Patrizia Rubini, Lumei Huang, et al.
Expert Opinion on Therapeutic Targets (2019) Vol. 23, Iss. 3, pp. 165-176
Closed Access | Times Cited: 42

Purinergic receptors in multiple sclerosis pathogenesis
Marı́a Domercq, Amaia Zabala-Letona, Carlos Matute
Brain Research Bulletin (2018) Vol. 151, pp. 38-45
Closed Access | Times Cited: 40

Pannexin‐1 mediated ATP release in adipocytes is sensitive to glucose and insulin and modulates lipolysis and macrophage migration
Marco Tozzi, Jacob B. Hansen, Ivana Novak
Acta Physiologica (2019) Vol. 228, Iss. 2
Open Access | Times Cited: 40

Structure-Guided Modification of Heterocyclic Antagonists of the P2Y14 Receptor
Jinha Yu, Antonella Ciancetta, Steven Dudas, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 11, pp. 4860-4882
Open Access | Times Cited: 39

Non-Cytotoxic Agarose/Hydroxyapatite Composite Scaffolds for Drug Release
Markus Witzler, Patrick Frank Ottensmeyer, Martin Gericke, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 14, pp. 3565-3565
Open Access | Times Cited: 39

The Metabotropic Purinergic P2Y Receptor Family as Novel Drug Target in Epilepsy
Mariana Alves, Edward Beamer, Tobías Engel
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 38

The Molecular Determinants of Small-Molecule Ligand Binding at P2X Receptors
Gaia Pasqualetto, Andrea Brancale, Mark T. Young
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 38

Insulin Resistance in Osteoarthritis: Similar Mechanisms to Type 2 Diabetes Mellitus
Elena V. Tchetina, Galina A. Markova, Е. П. Шарапова
Journal of Nutrition and Metabolism (2020) Vol. 2020, pp. 1-16
Open Access | Times Cited: 37

Medicinal chemistry of P2 and adenosine receptors: Common scaffolds adapted for multiple targets
Kenneth A. Jacobson, Adriaan P. IJzerman, Christa E. Müller
Biochemical Pharmacology (2020) Vol. 187, pp. 114311-114311
Open Access | Times Cited: 36

Therapeutic Strategies to Target Calcium Dysregulation in Alzheimer’s Disease
Maria Calvo‐Rodriguez, Elizabeth K. Kharitonova, Brian J. Bacskai
Cells (2020) Vol. 9, Iss. 11, pp. 2513-2513
Open Access | Times Cited: 34

CD39 and CD73 as Promising Therapeutic Targets: What Could Be the Limitations?
Ana Maria Oliveira Battastini, Fabrício Figueiró, Daniela Bitencourt Rosa Leal, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 32

P2X7 receptor in multifaceted cellular signalling and its relevance as a potential therapeutic target in different diseases
Abtar Mishra, Assirbad Behura, Ashish Kumar, et al.
European Journal of Pharmacology (2021) Vol. 906, pp. 174235-174235
Closed Access | Times Cited: 32

Inosine as a Tool to Understand and Treat Central Nervous System Disorders: A Neglected Actor?
Francisney Pinto do Nascimento, Sérgio José Macedo-Júnior, Fernanda Rocha Lapa-Costa, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 32

Microglial remodeling of actin network by Tau oligomers, via G protein‐coupled purinergic receptor, P2Y12R‐driven chemotaxis
Rashmi Ranjan Das, Subashchandrabose Chinnathambi
Traffic (2021) Vol. 22, Iss. 5, pp. 153-170
Open Access | Times Cited: 31

Pannexin-1 channel opening is critical for COVID-19 pathogenesis
Ross H. Luu, Silvana Valdebenito, Eliana Scemes, et al.
iScience (2021) Vol. 24, Iss. 12, pp. 103478-103478
Open Access | Times Cited: 30

Purinergic signaling: a potential therapeutic target for depression and chronic pain
Yuting Zou, Runan Yang, Lin Li, et al.
Purinergic Signalling (2021) Vol. 19, Iss. 1, pp. 163-172
Open Access | Times Cited: 29

Estrogen downregulates CD73/adenosine axis hyperactivity via adaptive modulation PI3K/Akt signaling to prevent myocarditis and arrhythmias during chronic catecholamines stress
Marie Louise Ndzie Noah, Gabriel Komla Adzika, Richard Mprah, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 12

The neuroinflammatory astrocytic P2X7 receptor: Alzheimer’s disease, ischemic brain injury, and epileptic state
Young Ha Ahn, Yong Tang, Péter Illés
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 9, pp. 763-778
Open Access | Times Cited: 11

Global trends of purinergic receptors and depression: A bibliometric analysis from 2003 to 2023
Biao Huang, Weining Chen, Chun-mei Peng, et al.
World Journal of Psychiatry (2025) Vol. 15, Iss. 2
Closed Access

P2Y12-mediated HIV gp120 and ddC-induced neuropathic pain improved by esculin
Zhihua Yi, Han Si, Shangdong Liang, et al.
Neuroreport (2025)
Closed Access

Platelets promote cartilage repair and chondrocyte proliferation via ADP in a rodent model of osteoarthritis
Qi Zhou, Chunhua Xu, Xingyao Cheng, et al.
Platelets (2015) Vol. 27, Iss. 3, pp. 212-222
Closed Access | Times Cited: 38

Scroll to top